Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3

BACKGROUND: The protease inhibitor, TL-3, demonstrated broad efficacy in vitro against FIV, HIV and SIV (simian immunodeficiency virus), and exhibited very strong protective effects on early neurologic alterations in the CNS of FIV-PPR infected cats. In this study, we analyzed TL-3 efficacy using a...

Descripción completa

Detalles Bibliográficos
Autores principales: de Rozières, Sohela, Swan, Christina H, Sheeter, Dennis A, Clingerman, Karen J, Lin, Ying-Chuan, Huitron-Resendiz, Salvador, Henriksen, Steven, Torbett, Bruce E, Elder, John H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535546/
https://www.ncbi.nlm.nih.gov/pubmed/15555065
http://dx.doi.org/10.1186/1742-4690-1-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535546/
https://www.ncbi.nlm.nih.gov/pubmed/15555065
http://dx.doi.org/10.1186/1742-4690-1-38

Ejemplares similares